Page last updated: 2024-08-23
paclitaxel and jaw
paclitaxel has been researched along with jaw in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Higgins, LS; Orlowski, RZ; Shi, YY; Small, GW | 1 |
Other Studies
1 other study(ies) available for paclitaxel and jaw
| Article | Year |
|---|---|
Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
Topics: Apoptosis; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Doxorubicin; Drug Interactions; Drug Resistance, Neoplasm; Dual Specificity Phosphatase 1; Enzyme Activation; Humans; Immediate-Early Proteins; Indoles; MAP Kinase Kinase 4; Mechlorethamine; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Phosphoprotein Phosphatases; Protein Phosphatase 1; Protein Tyrosine Phosphatases | 2007 |